— McKesson Corporation (NYSE: MCK) reported third-quarter 2019 earnings of $3.60 per share, in line with the street projection.
— Total revenue grew 9% to $57.62 billion, vs $55.07 billion expected. The topline was driven by its US Pharmaceutical and Specialty Solutions segment.
— Revenues from US Pharma segment were $46.0 billion, up 10%, driven by branded pharmaceutical price increases and increased specialty pharmaceutical volumes.
— Reaffirms fiscal 2020 adjusted EPS guidance range of $14.00 – $14.60.
— CME shares have gained 0.7% immediately following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Earnings Preview: What to look for when Kroger (KR) reports Q1 2025 results
The Kroger Co. (NYSE: KR) is expected to report its first-quarter financial results next week. Customer engagement remained stable last year, driven by high-quality products and tailored promotional offers. Recently,
Adobe (ADBE) Q2 adjusted earnings rise on higher revenues
Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in revenue and adjusted profit for the second quarter of 2025, amid continued growth in its subscription-based business. The design software
ORCL Earnings: Highlights of Oracle’s Q4 2025 financial report
Technology giant Oracle Corporation (NYSE: ORCL) has reported higher revenues and adjusted earnings for the fourth quarter of 2025. Total revenues increased to $15.9 billion in the May quarter from